Dermatology 2023 | International Conference on Dermatology and cosmetology

A recent Federal Trade Commission civil lawsuit accusing one of the nation's largest anesthesiology groups of monopolistic practices that sharply drove up prices is a warning to private equity investors that could temper their big push to snap up physician groups. source https://www.news-medical.net/news/20231130/FTC-chief-gears-up-for-a-showdown-with-private-equity.aspx

A heat shock protein protects the cells against protein clumping. It degrades, however, over longer treatment periods. source https://www.news-medical.net/news/20231124/Heat-shock-protein-protects-bacteria-from-plasma-treatment.aspx

As an extremely aggressive form of skin cancer, cutaneous melanoma is still associated with a high mortality rate. Enormous progress has recently been made in the fight against deadly metastasis, but existing therapeutic measures are still not effective in many cases. source https://www.news-medical.net/news/20231121/Researchers-discover-new-option-to-target-the-metastatic-capacity-of-melanoma-cells.aspx

Almirall S.A., a global biopharmaceutical company focused on medical dermatology, and Absci Corporation, a generative AI drug creation company, today announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases. The partnership combines Absci’s Integrated Drug Creation™ platform with Almirall’s dermatological expertise with the goal of delivering life-changing medicines to patients, marking another step forward in AI drug creation. source https://www.news-medical.net/news/20231120/Almirall-and-Absci-partner-to-develop-AI-designed-therapeutics-for-dermatological-diseases.aspx

Money talks. The United States faces a serious shortage of primary care physicians for many reasons, but one, in particular, is inescapable: compensation. source https://www.news-medical.net/news/20231116/Compensation-is-key-to-fixing-primary-care-shortage.aspx

The Paul G. Allen Frontiers Group, a division of the Allen Institute, today announced the launch of the Allen Discovery Center (ADC) for Neuroimmune Interactions at the Icahn School of Medicine at Mount Sinai. source https://www.news-medical.net/news/20231109/Allen-Discovery-Center-for-Neuroimmune-Interactions-launched-at-Mount-Sinai.aspx

A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University. source https://www.news-medical.net/news/20231106/New-pathologic-scoring-system-could-help-predict-survival-in-lung-cancer-patients.aspx